Healthcare -
Biotechnology - NASDAQ - US
$ 4.01
-2.44 %
$ 228 M
Market Cap
-4.04
P/E
DSGN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities DSGN - Design Therapeutics, Inc.
44 M
LAST VALUE
48.29%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR